Item 8.01 Other Events.
On
The new patent extends the Know Labs IP portfolio to nearly 90 patents issued and pending, reinforcing the Company's position as a top worldwide IP holder in non-invasive blood glucose monitoring.
A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description of Exhibit 99.1 Press Release dated January 4, 2023 - Filed herewith. - 2 -
--------------------------------------------------------------------------------
© Edgar Online, source